Btr Capital Management Inc / ABT
Btr Capital Management Inc’s Abbott Laboratories Position
Does Btr Capital Management Inc own Abbott Laboratories (ABT)? Yes — 105.0K shares worth $10M (+1.59% of its 13F portfolio) as of Q3 2022, down from 106.1K shares the prior filed quarter.
Position Value
$10M
Q3 2022
Shares
105.0K
% of Portfolio
+1.59%
Quarters Held
16
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2022 | 105.0K | $10M | +1.59% |
| Q2 2022 | 106.1K | $12M | +1.65% |
| Q1 2022 | 106.9K | $13M | +1.56% |
| Q4 2021 | 106.9K | $15M | +1.70% |
| Q3 2021 | 105.5K | $12M | +1.54% |
| Q2 2021 | 107.5K | $12M | +1.56% |
| Q1 2021 | 100.6K | $12M | +1.75% |
| Q4 2020 | 101.0K | $11M | +1.73% |
| Q3 2020 | 101.8K | $11M | +1.96% |
| Q2 2020 | 104.1K | $10M | +1.79% |
| Q1 2020 | 104.3K | $8M | +1.82% |
| Q4 2019 | 102.1K | $9M | +1.53% |
| Q3 2019 | 103.8K | $9M | +1.63% |
| Q2 2019 | 105.6K | $9M | +1.66% |
| Q1 2019 | 107.4K | $9M | +1.65% |
| Q4 2018 | 111.2K | $8M | +1.69% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Btr Capital Management Inc’s full portfolio or all institutional holders of ABT.